MariMed Q2 Adj. EPS $(0.01), Inline, Sales $41.925M Beat $39.800M Estimate
MariMed (OTC:MRMD) reported quarterly losses of $(0.01) per share which met the analyst consensus estimate. The company reported quarterly sales of $41.925 million which beat the analyst consensus estimate of $39.800
Read original at benzinga